Product Overview

To address the low recovery and high synthesis cost associated with traditional solid-phase synthesis of long peptides, Hzymes has developed a recombinant fermentation-based manufacturing approach for Amycretin, providing an alternative solution for peptide development and production.

Key Features

Recombinant Fermentation-Based Production

Utilizes a biological fermentation approach as an alternative manufacturing strategy for long peptides, addressing challenges associated with traditional solid-phase peptide synthesis.

Cost-Efficient Manufacturing

Designed to improve manufacturing efficiency and potentially reduce production costs for complex peptide molecules.

High Purity and Quality Consistency

Employs optimized expression, cleavage, and purification processes to support high product quality and batch-to-batch consistency.

Scalable Production Capability

Supports project needs from process development to larger-scale manufacturing, enabling flexible production according to customer requirements.

Quality System Support

Developed and manufactured under an established quality management system with documented process controls and traceability.

Applications

Amycretin Development Programs

Suitable for the development and production of recombinant fermented Amycretin for research and manufacturing applications.

Long Peptide Manufacturing

Applicable to peptide programs where long peptide length presents challenges for conventional solid-phase synthesis.

Process Development and Scale-Up

Supports process optimization, pilot production, and scale-up activities throughout peptide development.

Peptide Drug Development

Can be applied to the development and manufacture of recombinant fermented peptide therapeutics requiring scalable and quality-controlled production.

Performance Data